(-)-alpha-phellandrene increases expression ISO RGD:1312845 6480464 alpha phellandrene results in increased expression of CYFIP2 mRNA CTD PMID:25075043 1,1-dichloroethene decreases expression ISO RGD:1312846 6480464 vinylidene chloride results in decreased expression of CYFIP2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1312846 6480464 1, 2-Dimethylhydrazine results in increased expression of CYFIP2 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1312845 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of CYFIP2 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of CYFIP2 mRNA CTD PMID:20660070 , PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312846 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CYFIP2 mRNA more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYFIP2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312846 6480464 Tetrachlorodibenzodioxin results in increased expression of CYFIP2 mRNA CTD PMID:19759094 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312846 6480464 Tetrachlorodibenzodioxin affects the expression of CYFIP2 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYFIP2 mRNA CTD PMID:20959002 more ... 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CYFIP2 mRNA CTD PMID:21346803 2-butoxyethanol decreases expression ISO RGD:1312846 6480464 n-butoxyethanol results in decreased expression of CYFIP2 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:1312845 6480464 beta-methylcholine affects the expression of CYFIP2 mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of CYFIP2 mRNA CTD PMID:28522335 5-fluorouracil affects response to substance ISO RGD:1312845 6480464 CYFIP2 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 5-fluorouracil multiple interactions ISO RGD:1312845 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA], TP53 protein promotes the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA] CTD PMID:15016801 , PMID:17982676 5-fluorouracil increases expression ISO RGD:1312845 6480464 Fluorouracil results in increased expression of CYFIP2 mRNA CTD PMID:17039268 , PMID:17982676 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYFIP2 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of CYFIP2 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of CYFIP2 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1312846 6480464 Acrylamide results in decreased expression of CYFIP2 mRNA CTD PMID:29261810 aflatoxin B1 affects expression ISO RGD:1312845 6480464 Aflatoxin B1 affects the expression of CYFIP2 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1312845 6480464 Aflatoxin B1 results in increased methylation of CYFIP2 gene, Aflatoxin B1 results in increased methylation of CYFIP2 intron CTD PMID:27153756 , PMID:30157460 aflatoxin B1 increases expression ISO RGD:1312845 6480464 Aflatoxin B1 results in increased expression of CYFIP2 mRNA CTD PMID:21632981 , PMID:21641981 Aflatoxin B2 alpha decreases methylation ISO RGD:1312845 6480464 aflatoxin B2 results in decreased methylation of CYFIP2 intron CTD PMID:30157460 all-trans-retinoic acid multiple interactions ISO RGD:1312845 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of CYFIP2 mRNA CTD PMID:15894607 all-trans-retinoic acid increases expression ISO RGD:1312845 6480464 Tretinoin results in increased expression of CYFIP2 mRNA CTD PMID:15894607 more ... alpha-phellandrene increases expression ISO RGD:1312845 6480464 alpha phellandrene results in increased expression of CYFIP2 mRNA CTD PMID:25075043 antirheumatic drug decreases expression ISO RGD:1312845 6480464 Antirheumatic Agents results in decreased expression of CYFIP2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1312845 6480464 aristolochic acid I results in decreased expression of CYFIP2 mRNA CTD PMID:33212167 Aroclor 1254 increases expression ISO RGD:1312846 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYFIP2 mRNA CTD PMID:25270620 arsane multiple interactions ISO RGD:1312845 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYFIP2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1312845 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYFIP2 mRNA CTD PMID:32525701 arsenous acid multiple interactions ISO RGD:1312845 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYFIP2 mRNA CTD PMID:15894607 atrazine decreases expression ISO RGD:1312845 6480464 Atrazine results in decreased expression of CYFIP2 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:1312845 6480464 Benzo(a)pyrene results in increased expression of CYFIP2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases methylation ISO RGD:1312845 6480464 Benzo(a)pyrene results in decreased methylation of CYFIP2 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1312845 6480464 Benzo(a)pyrene affects the methylation of CYFIP2 5' UTR, Benzo(a)pyrene affects the methylation of CYFIP2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1312846 6480464 Benzo(a)pyrene results in increased expression of CYFIP2 mRNA CTD PMID:19770486 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:1312845 6480464 7 more ... CTD PMID:20382639 benzo[e]pyrene affects methylation ISO RGD:1312845 6480464 benzo(e)pyrene affects the methylation of CYFIP2 intron CTD PMID:30157460 beta-naphthoflavone decreases expression ISO RGD:1312845 6480464 beta-Naphthoflavone results in decreased expression of CYFIP2 mRNA CTD PMID:32858204 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYFIP2 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:1312845 6480464 bisphenol A results in decreased methylation of CYFIP2 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYFIP2 mRNA CTD PMID:32145629 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CYFIP2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYFIP2 mRNA, bisphenol A results in decreased expression of CYFIP2 protein CTD PMID:24552547 , PMID:35192832 buta-1,3-diene decreases expression ISO RGD:1312846 6480464 1, 3-butadiene results in decreased expression of CYFIP2 mRNA CTD PMID:29038090 carbamazepine affects expression ISO RGD:1312845 6480464 Carbamazepine affects the expression of CYFIP2 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1312846 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1312845 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYFIP2 gene] CTD PMID:28238834 chlordecone decreases expression ISO RGD:1312846 6480464 Chlordecone results in decreased expression of CYFIP2 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:1312846 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYFIP2 mRNA CTD PMID:20938992 cisplatin multiple interactions ISO RGD:1312845 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of CYFIP2 mRNA CTD PMID:21858171 cisplatin increases expression ISO RGD:1312845 6480464 Cisplatin results in increased expression of CYFIP2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1312845 6480464 Cisplatin results in decreased expression of CYFIP2 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:1312845 6480464 cobaltous chloride results in decreased expression of CYFIP2 mRNA CTD PMID:19320972 copper(II) chloride decreases expression ISO RGD:1312845 6480464 cupric chloride results in decreased expression of CYFIP2 mRNA CTD PMID:17211630 coumestrol decreases expression ISO RGD:1312845 6480464 Coumestrol results in decreased expression of CYFIP2 mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:1312845 6480464 Cyclosporine results in increased expression of CYFIP2 mRNA CTD PMID:19159671 , PMID:22147139 cyclosporin A decreases expression ISO RGD:1312845 6480464 Cyclosporine results in decreased expression of CYFIP2 mRNA CTD PMID:25562108 , PMID:27989131 dextran sulfate multiple interactions ISO RGD:1312846 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA CTD PMID:29950665 diarsenic trioxide multiple interactions ISO RGD:1312845 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYFIP2 mRNA CTD PMID:15894607 dibenzofurans increases expression ISO RGD:1312846 6480464 Dibenzofurans results in increased expression of CYFIP2 mRNA CTD PMID:34254344 dorsomorphin multiple interactions ISO RGD:1312845 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYFIP2 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1312845 6480464 Doxorubicin results in increased expression of CYFIP2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CYFIP2 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1312846 6480464 epoxiconazole results in decreased expression of CYFIP2 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1312846 6480464 Ethanol affects the expression of and affects the splicing of CYFIP2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1312845 6480464 Ethyl Methanesulfonate results in increased expression of CYFIP2 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:1312846 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYFIP2 mRNA CTD PMID:20938992 formaldehyde increases expression ISO RGD:1312845 6480464 Formaldehyde results in increased expression of CYFIP2 mRNA CTD PMID:23649840 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CYFIP2 mRNA CTD PMID:22061828 hydralazine multiple interactions ISO RGD:1312845 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA CTD PMID:17183730 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYFIP2 mRNA CTD PMID:22129741 ivermectin decreases expression ISO RGD:1312845 6480464 Ivermectin results in decreased expression of CYFIP2 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1312846 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYFIP2 mRNA CTD PMID:20938992 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CYFIP2 mRNA CTD PMID:24136188 methapyrilene affects methylation ISO RGD:1312845 6480464 Methapyrilene affects the methylation of CYFIP2 intron CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1312845 6480464 Methyl Methanesulfonate results in increased expression of CYFIP2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1312845 6480464 methylmercuric chloride results in decreased expression of CYFIP2 mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO RGD:1312846 6480464 methylmercuric chloride results in decreased expression of CYFIP2 mRNA CTD PMID:29261810 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of CYFIP2 gene CTD PMID:33148267 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYFIP2 mRNA CTD PMID:22129741 nickel atom increases expression ISO RGD:1312845 6480464 Nickel results in increased expression of CYFIP2 mRNA CTD PMID:24768652 , PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CYFIP2 mRNA CTD PMID:25729387 paracetamol increases expression ISO RGD:1312845 6480464 Acetaminophen results in increased expression of CYFIP2 mRNA CTD PMID:22230336 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of CYFIP2 gene CTD PMID:33148267 phenobarbital increases expression ISO RGD:1312846 6480464 Phenobarbital results in increased expression of CYFIP2 mRNA CTD PMID:19482888 pirinixic acid multiple interactions ISO RGD:1312845 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYFIP2 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYFIP2 mRNA CTD PMID:19162173 pirinixic acid increases expression ISO RGD:1312846 6480464 pirinixic acid results in increased expression of CYFIP2 mRNA CTD PMID:20813756 piroxicam multiple interactions ISO RGD:1312845 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of CYFIP2 mRNA CTD PMID:21858171 poly(I:C) multiple interactions EXP 6480464 [Poly I-C co-treated with HU 211] results in decreased expression of CYFIP2 mRNA CTD PMID:26923065 potassium chromate increases expression ISO RGD:1312845 6480464 potassium chromate(VI) results in increased expression of CYFIP2 mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:1312845 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of CYFIP2 mRNA CTD PMID:20660070 progesterone decreases expression ISO RGD:1312845 6480464 Progesterone results in decreased expression of CYFIP2 mRNA CTD PMID:20864642 propanal increases expression ISO RGD:1312845 6480464 propionaldehyde results in increased expression of CYFIP2 mRNA CTD PMID:26079696 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYFIP2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1312845 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYFIP2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1312846 6480464 Silicon Dioxide results in increased expression of CYFIP2 mRNA CTD PMID:29203145 sodium arsenate multiple interactions ISO RGD:1312845 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYFIP2 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:1312845 6480464 sodium arsenite results in decreased expression of CYFIP2 protein CTD PMID:30528433 sulforaphane increases expression ISO RGD:1312846 6480464 sulforaphane results in increased expression of CYFIP2 mRNA CTD PMID:30529165 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CYFIP2 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CYFIP2 mRNA CTD PMID:30012374 titanium dioxide multiple interactions ISO RGD:1312846 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA CTD PMID:29950665 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CYFIP2 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:1312845 6480464 trichostatin A results in decreased expression of CYFIP2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1312845 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYFIP2 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:1312846 6480464 trimellitic anhydride results in increased expression of CYFIP2 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CYFIP2 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:1312846 6480464 triptonide results in increased expression of CYFIP2 mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO RGD:1312846 6480464 trovafloxacin results in decreased expression of CYFIP2 mRNA CTD PMID:35537566 tungsten decreases expression ISO RGD:1312846 6480464 Tungsten results in decreased expression of CYFIP2 mRNA CTD PMID:30912803 valproic acid increases methylation ISO RGD:1312845 6480464 Valproic Acid results in increased methylation of CYFIP2 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1312845 6480464 Valproic Acid results in increased expression of CYFIP2 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:1312845 6480464 Valproic Acid affects the expression of CYFIP2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1312846 6480464 Valproic Acid results in increased expression of CYFIP2 mRNA CTD PMID:21427059 valproic acid multiple interactions ISO RGD:1312845 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA CTD PMID:17183730 vancomycin increases expression ISO RGD:1312846 6480464 Vancomycin results in increased expression of CYFIP2 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYFIP2 mRNA CTD PMID:23869203 zoledronic acid decreases expression ISO RGD:1312845 6480464 zoledronic acid results in decreased expression of CYFIP2 mRNA CTD PMID:24714768
